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Eye movement deficits are frequently noted in multiple sclerosis during bedside
clinical examination, but subtle dysfunction may remain undetected and might only be
identified with advanced approaches. While classical neurology provides insight into
the complex functional anatomy of oculomotor functions, little is known about the
structural background of this dysfunction in MS. Thirty four clinically stable, treated
relapsing-remitting MS patients with mild disability and 34 healthy controls were included
in our study. Group difference and correlation with clinical parameters were analyzed in
case of the latency, peak-velocity, gain, dysconjugacy index, and performance during a
saccade and anti-saccade task. High-resolution T1 weighted, T2 FLAIR, and double
inversion recovery images were acquired on 3T to evaluate the correlation between
behavioral and MRI parameters, such as T2 lesion and T1 black-hole burden, global
brain, gray, and white matter atrophy. VBM style analysis was used to identify the
focal gray matter atrophy responsible for oculomotor dysfunction. Significantly increased
latency in the prosaccade task and significantly worse performance in the anti-saccade
task were found in MS patients. The detailed examination of conjugated eye movements
revealed five subclinical internuclear ophthalmoparesis cases. The peak velocity and
latency of the anti-saccade movement correlated with the number of black holes, but
none of the eye movement parameters were associated with the T2 lesion burden or
location. Global gray matter volume correlated with saccade and anti-saccade latency,
whereas white matter and total brain volume did not. Local gray matter atrophy in the left
inferio-parietal lobule and temporo-occipital junction correlated with anti-saccade peak
velocity. Our results show that neurodegeneration-like features of the MRI (black-hole,
gray matter atrophy) are the best predictors of eye movement deficit in MS. Concurring
with the clinico-radiological paradox, T2 lesion burden cannot explain the behavioral
results. Importantly, anti-saccade peak velocity correlates with gray matter atrophy in
the left parietal regions, which are frequently implicated in attention tasks.
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INTRODUCTION
Multiple sclerosis (MS) is a devastating disease that mostly
affects young adults. Among many other symptoms, oculomotor
deficit is common in MS, reported to occur in 57–70% of
all patients (1, 2). Its significance lies in the observation that
the presence of eye movement abnormality is associated
with greater disability and greater disability progression
(3). Bedside oculo-motor examination by an experienced
specialist could reveal major oculomotor deficits, but subtle
alterations might remain undetected. Eye tracker devices are
suitable for objective and quantitative measurements of eye
movements and are more sensitive in detecting subclinical
abnormalities (1).
The aim of the eye movements is to keep the object
of interest on the fovea. These voluntary and reflexive
movements are the rapid jerky saccades, the smooth pursuit
and vergence movements. These intricate ocular movements are
accomplished by six extraocular muscles, the movement of which
is coordinated by a complex network of cortical and subcortical
neuronal elements.
The main purpose of the rapid voluntary conjugate eye
movements known as saccades, is to bring the new object
of interest onto the foveae. The cranial nerve nuclei of
the oculomotor muscles could be found in the brainstem.
In addition, other elements of the premotor circuits of
saccades are in the brainstem such as the paramedian pontine
reticular formation, nucleus of the medial longitudinal
fasciculus and nucleus raphe interpositius. All of these
regions receive afferents from the superior colliculus.
Moreover, the behaviorally important stimuli are processed
in various cortical networks and together with fronto-parietal
attention networks have crucial role in guiding eye movements
during saccades (4). Eventually the cortical signals for eye
movements are generated in the frontal eye filed (FEF) in
close interaction with other centers such as supplementary and
pre-supplementary eye fields (5), the dorsolateral prefrontal
cortex and parietal cortex. From the cortical centers the
information is conveyed via the superior colliculus to the
nuclei of the oculomotor nerves directly and indirectly as
well (6–8). Over the course of information flow various
subcortical, brainstem and cerebellar centers are modulating
the process.
Damage to certain parts of this network causes clinically
abnormal eyemovement (9, 10) some of those easily detectable by
bedside examination (11). However, the structural background
of subtle eye movement deficits in MS is not well-understood.
Damage of the perceptual systems, the cognitive networks such as
attention and the eye movement centers cause various alterations
of eye movements.
The aim of our study was to investigate the subclinical
oculomotor deficit of MS patients in prosaccade and anti-
saccade tasks. The higher order structural background of such
abnormal eye movements was investigated by correlating
the behavioral measures with lesion location and gray
matter atrophy.
MATERIALS AND METHODS
Subjects
Thirty nine relapsing remitting MS patients were enrolled in our
study. Inclusion criteria for patients were: relapsing remittingMS
on disease modifying treatment, EDSS score <6, no relapse in
the preceding 3 months, no other major neurological, psychiatric
or ophthalmological disease (for clinical and demographic data
see Table 1).
We also recruited 34 healthy controls (HC), who had nomajor
neurological, psychiatric, or ophthalmological disease.
This study was carried out in accordance with the
recommendations of the Medical Research Council National
Scientific and Ethical Committee (ETT TUKEB) with written
informed consent from all subjects. All subjects gave written
informed consent in accordance with the Declaration of Helsinki.
The protocol was approved by the National Institute of Pharmacy
and Nutrition (000002/2016/OTIG).
Visuo-Motor Task
The subjects completed a prosaccade and an anti-saccade task.
The investigation took place in a well-lit room. The subjects
sat 60 cm away from the screen. The visual stimuli and the
task paradigm were written using the Tobii MATLAB binding1
and the Psychophysics Toolbox Version 3.0.122, under MatLab
8.3.0.532 (2014a, MathWorks, Inc.). Eye movement recording
was carried out with a Tobii TX300 eyetracker. Before the task,
a 5 points calibration was carried out. The prosaccade task was
the following: A black cross appeared in the center of a gray
screen, which disappeared after a random interval of 1.2–2 s
and appeared instantaneously in the left or right side of the
screen, 9.2 or 18.4◦From the center. Each condition (4 in all: left-
far, left-close, right-far, right-close) was repeated 20 times in a
pseudorandom order. Subjects had to move their gaze to the new
location of the target instantly and accurately. Halfway during the
task, there was a break to prevent subjects from fatigue and/or
tearing. In the anti-saccade task, the layout was the same, but the
subjects had to move their gaze contralateral to the position of
the new target.
The data acquisition started when the target (cross) jumped
to the periphery and lasted 1 s. The sampling frequency was
300Hz. Data from both eyes were recorded simultaneously. Each
recorded data point had a time stamp and a validity code. After
the data acquisition, the target jumped back to the center of
the screen.
Data Processing
The recorded data was processed oﬄine. Trials in which more
than 10% of the data was missing (validity code higher than 1 as
provided by the eye tracker) or more than 100ms was missing
continuously or more than 80% was missing in the first 50ms
were excluded from further analysis. In the rest of the trials,
missing values were interpolated with linear interpolation of the
neighboring values.
1http://developer.tobiipro.com/matlab.html
2http://psychtoolbox.org/
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TABLE 1 | Demographic data of the subjects.
Group # of subjects Females Age
(years)
EDSS Disease duration
(months)
Treatment regimen
MS 39 25 39.1(±9.5) 1.4(±1.4) 103(±72.8) DF-15%
Te-28%
IFNb-13%
GA-18%
F-26%
HC 34 23 31(±10.9) – – –
DF, dimethyl fumarate; Te, teriflunodamide; IFNb, interferon beta 1a; GA, glatiramer acetate; F, fingolimid.
The preprocessed data were smoothed and differentiated with
a 0, 1st and 2nd order 11-points sliding window Savitzky-Golay
filter3 to calculate the position, velocity and acceleration of the
eyes. Saccades were detected automatically: if the velocity of the
eye exceeded 50◦/s in 2 consecutive points it was labeled as a
saccade like event. The beginning of the saccade like event was
marked where the acceleration of the eye was 0 (or reached its
minimum value in 50ms before its peak). The end of the saccade
like event was marked where its velocity reached zero after the
peak. Saccade like motion was accepted as a saccade if its latency
occurred between 100 and 600ms after stimulus onset, it took at
least 12ms and a fixation preceded the saccade like event. During
fixation the eye had to be close to the initial cross (<1.5◦) and its
position change over the fixation had to be <0.6◦. For all trials
the position-time diagram was checked visually and inadequate
trials were excluded. The first two trials in each condition were
seen as practice and excluded from further analysis. A condition
was accepted if the subject had at least 9 trials (half of the trials
in a condition) after exclusion. Saccade latency (the start of the
saccade), saccade peak velocity, saccade amplitude and saccade
duration were assessed. Saccade gain was calculated from the
ratio of the final eye position and the target position. Anti-
saccade latency, gain, peak velocity were determined similarly
in the correctly performed trials. Anti-saccade performance was
calculated as the percentage of correctly performed trials to all
the adequate trials. Moreover, a dysconjugacy index (DI) was
calculated in the saccade task from both eyes as the ratio of the
abducting and adducting eye’s velocity in the “long” condition. DI
was determined in the left and right directions. Patient’s Z-scores
were calculated as indicated in Equation 1.
ZDI =
DI(MS)−mean (DI (HC))
STD (DI (HC))
(1)
Magnetic Resonance Imaging
Magnetic resonance imaging was performed with a 3 T GE
Discovery 750w MR Scanner (GE Healthcare, Chalfont St. Giles,
UK). The MR images used in the current study were acquired
as part of the routine follow up of the patients, the protocol
of which is described in details in our recent recommendation
(12). The following sequences were used in the current analysis:
High resolution T1 weighted anatomical images (3D spoiled
3https://www.mathworks.com/matlabcentral/fileexchange/30299-savitzky-golay-
smooth-differentiation-filters-and-filterapplication
gradient echo images with inversion recovery (3D FSPGR IR:
echo time [TE]: 2ms; repetition time [TR]: 5.4ms; inversion time
[TI]: 450ms; matrix: 256 ∗ 256; field of view [FOV]: 25.6 cm ∗
25.6 cm; flip angle: 12◦; slice thickness [sl]: 1mm; PURE intensity
correction), CUBE T2 FLAIR for lesion detection (TE: 135ms;
TR: 6700ms; TI: 1827ms; matrix: 256∗224; FOV: 25∗22.5 cm, sl:
1.4mm; fat sat; post processing: ZIP512, ZIP2), CUBE double
inversion recovery (DIR) (TE: 90ms; TR: 7,000ms; TI: 2,901ms;
blood suppression TI: 546ms; matrix: 192∗192; FOV: 25 cm ∗
25 cm; sl: 1.4mm; fat sat) and spin echo (SE) T1 weighted images
were acquired (TE: min full, TR: 500, flip angle: 73◦; matrix:
256∗224, FOV: 24 cm ∗ 19.2, sl: 3mm, NEX: 2).
Image Analysis
Lesion load was determined in the periventricular, infratentorial,
and juxtacortical regions on the FLAIR and DIR images
manually. Lesion load in the whole brain as well as in the
above-mentioned subregions was correlated with the behavior
parameters. The SE T1 images were used for determine black
hole burden.
The correlation of lesion location probability and eye
movement deficit was evaluated as described by Kincses et al.
(13). Binary lesion mask were brought into standard space
by registering the FLAIR images to the high resolution T1
weighted images by 6 DOF linear registration (14) and the
T1 weighted images to standard MNI152 space by non-linear
registration (15). The standard space binary lesion masks
were concatenated. A voxelwise GLM analysis was performed,
the regressors of the design matrix were the measured eye
movement parameters. Non-parametric permutation test, with
5,000 permutations were used for statistical inference with
correction for multiple comparisons.
The high resolution T1 weighted images were used for voxel-
based morphometry analysis. We employed an “optimized”
VBM-style protocol (16, 17) using FSL (18). Non-brain parts
were removed from all structural images (19) and tissue-type
segmentation was carried out by FAST4 (20). The resulting gray
matter partial volume images were registered to standard space
(MNI152) using linear transformation (14) followed by a non-
linear registration (15). The resulting images were averaged to
create a study-specific template, to which the native gray matter
images were then non-linearly re-registered. The registered
partial volume images were then modulated (to correct for local
expansion or contraction) by dividing by the Jacobian of the warp
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field. The modulated segmented images were then smoothed
with an isotropic Gaussian kernel with a sigma of 2mm.
Finally, voxelwise GLM was applied and permutation-based
non-parametric testing correcting for multiple comparisons
across space was used for statistical inference. The design
matrix contained the behavior parameters (saccade latency,
peak velocity, and gain) in consecutive analyses. The model
was adjusted for disease duration and age. Thresholding was
carried out by cluster-based thresholding corrected for multiple
comparison by using cluster size.
Statistical Analysis
Statistical analysis was carried out with Rstudio (21). The
following packages were used: lme4 (22)—model building, car
(23)—statistical significance. Mean and standard error were
calculated for the following parameters: latency, peak velocity
and gain from both eyes in the prosaccade and anti-saccade
tasks separately. All parameters were evaluated in a mixed model
ANOVA, in which the subject was the random effect and the
group (HC-MS), the movement type (abduction-adduction), and
the distance (far-close) of the target handled as fixed effects.
A p < 0.05 was considered significant. We investigated both
eyes separately because an average of the two eyes could be
misleading if subclinical internuclear ophthalmoparesis coexists.
The results from the left eye were reported unless otherwise
stated. To investigate oculomotor decision, latency and peak
velocity differences between prosaccade/anti-saccade tasks were
calculated and compared between the groups. The name of
the new calculated variables were peak velocity difference and
latency difference. As peak velocity and amplitude have linear
relationship in case of significance the statistic was repeated
with the scaled peak velocities. Pearson or Spearman correlation
(where the assumptions of the Pearson were not valid) between
MRI markers and behavior parameters were calculated in
separate analyses. The effect of disease duration and age was
tested in partial correlation and the effect of sex is tested via
comparing the Fischer Z transformed correlation coefficients in
the two sex separately. Correlation coefficient are reported from
simple correlation where the age, disease duration and sex had no
effect on the association.
RESULTS
Clinical examination indicated that 5 patients (13%) had
clinically detectable oculomotor alteration. They were excluded
from further quantitative analysis. One further patients was also
excluded because of technical issues with the MRI images. The
demographical data of subjects are presented in Table 1. All
patients were on disease modifying therapy (6 patients take
dimethyl-fumarate, 11-teriflonomide, 4- i.m. interferon beta1a,
7-glatiramer acetate, 10-fingolimod, 1-s.c interferon beta1a).
The average total lesion number was 21 (±15). As expected,
most of the lesions occurred in the periventricular region
(12.5±7.6), but significant lesion load was found in the
infratentorial and juxtacortical location too (1.5 ±1.6, 3.6
±4.5, respectively).
FIGURE 1 | Mean and ±SEM of latency in different conditions of the left eye in
the saccade task. Significant group difference is marked with an asterisk (*).
The mean and standard error from the left-upper part of the figure were the
following: 198(±5)ms vs. 221(±7)ms (abduction+long), 206(±5)ms vs.
224(±7)ms (adduction+long), 183(±4)ms vs. 197(±6)ms (abduction+short),
188(±5)ms vs. 200(±6)ms (adduction+short) for HC and MS, respectively.
Latency
The latency of the anti-saccades were longer than the latency of
saccades (194ms vs. 303ms, t = −17.3, p < 0.0001 for HCs and
207ms vs. 319ms, t =-18.6, p < 0.0001 for MS participants).
Saccade latency was significantly prolonged in MS patients.
The results were similar in both eyes [left: F(1, 65.966) = 5.36,
p = 0.024, right: F(1, 65.98) = 5.38, p = 0.024] [mean(±sd):
194(±24) ms vs. 207(±31) ms for HC and MS participants].
There were no interaction effects between the fixed effects (group,
movement type and distance of the target). The results are
depicted in Figure 1.
Anti-saccade latency was prolonged in MS patients, however
it did not reach a significant level [F(1, 64.96) = 2.39, p = 0.12]
[mean(±sd):303(±44) ms vs. 319(±44) ms for HC and
MS, respectively].
The latency difference between prosaccade and anti-saccade
tasks was also investigated on group level and we found no
significant difference. [t(64) = 0.29, p = 0.77] [mean(±sd):
107(±36) ms vs. 112(±34) ms for HC and MS, respectively].
Peak Velocity
Prosaccade peak velocity was slightly smaller in the MS
group [mean(±sd): 325(±32)◦/s vs. 310(±42)◦/s for HC and
MS, respectively] but there was no significant difference
between the two groups [F(1, 65.96) = 1.4, p = 0.28].
However, a significant interaction effect could be observed
in two conditions: (i) group x movement type [left eye:
F(1, 187.1) = 3.3, p = 0.071, right eye: F(1, 192.7) = 7.2,
p = 0.0079], which means that the higher velocity of
adduction compared to abduction in HC was reversed in
MS patients, resulted in a higher peak velocity in abduction
compared to adduction and (ii) group x distance pleft eye:
F(1, 187.1) = 7.7, p = 0.006, right eye: F(1, 192.2) = 7.15, p = 0.008],
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FIGURE 2 | Mean and ± SEM of peak velocity in different conditions of the left
eye in the saccade task. Significant group* distance interaction is marked with
an asterisk (*). The mean and standard error are the following from left to right:
379(±9)/s vs. 366(±8)/s (abduction+long), 266(±4)/s vs. 265(±4)/s
(abduction+short), 389(±7)/s vs. 359(±12)/s (adduction+long), 269(±4)/s vs.
260(±7)/s (adduction+short) for HC and MS, respectively.
which means that the slower peak velocity in the closer
cue condition in HC group was slightly smaller in the MS
group (Figure 2).
Anti-saccade peak velocity was not different between the two
groups [F(1, 64.8) = 0.12, p = 0.73] [mean(±sd): 265(±46)
◦/s
vs. 268(±41)◦/s for HC and MS, respectively]and no interaction
effects could be observed.
Difference between prosaccade and anti-saccade peak velocity
could be observed in a group level.MS group had lower difference
in peak velocity around 20/s [t(64)= 2.13, p= 0.037] [mean(±sd):
60(±33)◦/s vs. 42(±37)◦/s for HC and MS, respectively],
however, this difference was not survived scaling for amplitude
[t(64) = 0.07, p= 0.95].
Moreover, EDSS scores positively correlated with peak
velocity difference (Spearman’s rho: 0.4, p = 0.024). The
higher clinical disability related to higher peak velocity difference
between the two tasks.
Gain
In the prosaccade task, MS group had smaller gain in all
conditions. Therefore, they performed slightly hypometric
saccades compared to HC. However, this difference did
not reach a significant level [F(1, 65.8) = 2.24, p = 0.14]
[mean(±sd): 0.932(±0.046) vs. 0.913(±0.049) for HC and MS,
respectively] (Figure 3).
Gain in the anti-saccade task did not differ between the two
groups [F(1, 63.6) = 0.01, p= 0.92].
Antisaccade Performance
There was a marked difference between the two groups in the
anti-saccade performance. The HC group reached more than
80% (±12.2%) accuracy while the MS group obtained only
FIGURE 3 | Mean and ± SEM of gain in different conditions of the left eye in
the saccade task. Slight hypometria could be detected, however, this
difference was not significant. Mean and standard error are the following from
left to right: 0.935(±0.012) vs. 0.918(±0.11) (abduction+long), 0.929(±0.012)
vs. 0.922(±0.011) (abduction+short), 0.926(±0.008) vs. 0.89(±0.011)
(adduction+long), 0.938(±0.01) vs. (adduction+short) for HC and MS,
respectively.
FIGURE 4 | Mean ± SEM of anti-saccade performance in the two groups.
Significant group difference is marked with an asterisk (*).
64% (±22.5%). (Wilcoxon-Mann-Whitney test: [U34, 33 = 837,
p < 0.001] (Figure 4).
Dyconjugacy Index
The dysconjugacy index derived from peak velocities of
the eyes can detect clinically not detectable internuclear
ophthalmoparesis (INO). A Z-value higher than the highest
control subject’s z-value+2 was determined as threshold for
subclinical INO (10). Based on this threshold five patients
were classified as having subclinical INO. Patient #49 had
INO in both directions, while patient #39, #37, and #17 had
only in the left direction and patient #18 only in the right
direction (Figure 5).
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FIGURE 5 | Z-scores of velocity dysconjugacy index individually, Subjects’
value higher than the cut-off are labeled.
FIGURE 6 | Antisaccade peak velocity of the left eye negatively correlated with
black-hole count.
Correlation of Eye Movement Deficit With
MRI Markers
T2 lesion burden or lesion location did not show significant
correlation with any of the measured MRI parameters.
A positive correlation were detected between anti-saccade
latency and the number of black-holes (Spearman’s rho: 0.45,
p = 0.011) and negative correlation between the anti-saccade
peak velocity and the number of black-holes (Spearman’s rho:
−0.47, p < 0.01) (Figure 6).
There were no significant correlation between white matter
volume with any of the measured eye movement parameters.
The VBM analysis revealed that anti-saccade peak velocity
correlated with gray matter density in parietal areas (Figure 7).
That is, smaller anti-saccade peak velocity was associated with
lower gray matter densities in the left parietal areas.
No other eye movement parameters showed correlation with
gray matter density.
FIGURE 7 | Results of VBM analysis. Marked voxels positively correlated with
anti-saccade peak velocity. The error bar represents different Z-value after
cluster based thresholding. Disease duration and age were used
as cofounders.
DISCUSSION
In our study we investigated visually guided prosaccade and
anti-saccade task performance in MS patients and their possible
association with focal brain alterations. Out of several eye
movement parameters, we found significantly increased latency
in the prosaccade task and significantly worse performance in
the anti-saccade task in MS patients. The detailed examination
of conjugated eye movements revealed 5 subclinical INO cases.
As regarding the MRI parameters, the peak velocity and
latency of the anti-saccademovement correlated with the number
of black-holes, but none of the eye movement parameters
were associated with the T2 lesion burden or location. Most
importantly, local gray matter atrophy in the left inferio-
parietal lobule and temporo-parietal junction correlated with
anti-saccade peak velocity.
Oculomotor alterations found with various paradigms such
as visually guided saccade, prosaccade, anti-saccade, memory
guided saccade and endogenous cued saccade are common inMS
(1, 3, 10, 24–31). In agreement with our findings, Clough et al.
found that saccade latency is prolonged in clinically definitiveMS
patients (24). In the same cohort, latency increases with longer
disease duration. In another study, the MS group has longer
saccade latency in the presence of a distractor stimulus (29).
Previous studies also showed that the performance is deteriorated
mainly in more cognitively demanding saccade tasks (3, 24–
28, 31). Antisaccade performance is deteriorated and associated
with cognitive performance (24, 28, 31). Fielding claims that
this alteration spares the reflexive part of the saccades. In our
investigation the anti-saccade peak velocity, but not that of the
parameters of the saccade task correlated with number of black-
holes and focal gray matter atrophy in the temporo-parietal
region. Prolonged latency of prosaccade could mirror the delayed
initiation of saccades. The prolonged latency of anti-saccades
however, might reflect a prolonged volitional decision process
or a delayed initiation of saccade in the opposite direction
or both (32). The difference might relates to the time, which
is not necessary for the reflexive part such as inhibition or
vector transformation (33). Hence the correlations we have
found are mainly reflecting the higher order cognitive processes
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of eye movements rather the reflexive parts. Interestingly, no
correlation was found between any of the MRI parameters and
the anti-saccade performance. The non-reflexive part of the anti-
saccades might be dysfunctional, leading to an error. While
if it is delayed but to a level that is not sufficient to make
an error it could only be investigated via its delayed latency.
This could especially be important in multiple sclerosis, in
which demyelination, and slowed conduction is a key feature of
the disease.
Saccades could be a potential marker to follow-up cognitive
alterations in MS patients because it has been shown that various
saccade performances are associated with cognition (24, 25, 27).
Based on these observations, prolonged latency could reflect
damage to networks associated with motor or cognitive control.
While several studies showed alterations of oculomotor
performance in MS, the background of such alterations is
not entirely clear. Clinically detectable oculomotor symptoms
show correlation with certain infratentorial lesions (9), but
in our investigation, subclinical eye movement deficit did not
correlate with T2 hyperintense lesion load, which is congruent
with the result of a previous study (31). It is in agreement
with our earlier investigation in that lesion load or location
only modestly correlate with clinical symptoms (13), whereas
persistent black-holes show better correlation with clinical and
cognitive functioning in MS (34, 35). Accordingly, the T1
hypointense lesion burden correlated with the anti-saccade
velocity and latency in our study. Brain atrophy showed
better correlation with clinical and cognitive disability (36). In
particular, cerebellar atrophy was associated with anti-saccade
error (31). In our study, gray matter atrophy measures correlated
with eye movement deficits globally as well as locally. Black holes
and atrophy seem to jointly relate to anti-saccade alterations.
Several studies found correlation between T1 black-hole lesions
and atrophy, but no similar relationship was revealed for T2
hyperintense lesions (37, 38). Cellular damage could be observed
in both cases (39, 40). In addition, both measures correlate well
with clinical disability, better than T2 lesion load (41).
Saccade peak velocity is affected by multiple cognitive
functions [arousal (42) and mental workload (43)]. In our study,
focal gray matter volume variability showed correlation with
anti-saccade peak velocity in the left inferior parietal lobule, left
temporo-parietal junction and in the putative left V5/MTmotion
sensitive visual region (44). These parietal regions are identical
to those frequently implicated in attention tasks (45). In their
seminal paper, Corbetta et al. in a remarkably similar paradigm
found activation in the intraparietal sulcus during sustained
attention and in the right temporo-parietal junction when a
target was detected, particularly at an unattended location (4).
These two conditions correspond to the top-down and bottom-
up attentional subsystems. Moreover, the parietal cortex has
its direct connection to the superior colliculus (6–8), and the
pontine nuclei as well (46). Damage to these perisylvian regions
was also implicated in neglect (47). Visuo-spatial neglect in MS
patients has been described, but no associated structural damage
has been found so far (48). Interestingly, the right temporo-
parietal junction is implicated in target detection, but in our study
the atrophy of the left temporo-parietal junction was associated.
Alternatively, parietal region has a potential role in saccades.
The parietal eye field and posterior parietal cortex are involved
in saccade generation (49) and visuospatial attention (45).
Moreover, human (50) and animal (51) studies suggested that this
region has a role in the vector inversion process, which is a crucial
step in anti-saccades.
In conclusion, saccades are substantially affected in MS
patients, which reflected in several behavior parameters.
Global and focal gray matter alterations are associated
with brain areas important in cognitive functions, such
as attention.
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